Powerful new medications such as Ozempic and Mounjaro, known as GLP-1 drugs are helping to win the war against obesity in ...

Experts say supplement companies have tried to capitalize on the GLP-1 craze, putting the phrase in their product names, ...

Contrave, which was approved by the FDA in 2014, belongs to a class of drugs called anorexiants and is intended for use in adults who are obese or overweight and have weight-related health conditions.

Dozens of lawmakers are urging U.S. health regulators to crack down on the booming market for knockoff weight-loss drugs amid ...

Experts say there’s no evidence GLP-1s can be absorbed through the skin — and these patches don’t contain the FDA-approved ...

More than 80 U.S. lawmakers asked the FDA to stop counterfeit GLP-1 drugs linked to Chinese suppliers from entering the ...

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

The Food and Drug Administration (FDA) approved Eli Lilly’s blockbuster diabetes drug for weight loss management Wednesday, giving patients another tool and opening the door to potentially much ...

There’s new help for diabetes patients battling weight gain. The U.S. Food and Drug Administration has approved a new drug to help overweight or obese adults manage their weight. The drug, to be ...

Several anti-obesity drugs, including Ozempic, Wegovy and Mounjaro, have created buzz in the Indian markets. But are they really approved for use in India? What are their side-effects? And how much do ...

Most compounded versions of popular drugs used for weight loss including Wegovy and Zepbound may soon no longer be available after a U.S. judge declined an initial injunction to allow compounding ...